Anti-COX1 Rabbit Polyclonal Antibody

Product#: SB-GB112399
$560.00
Availability:
Ships in 1-2 Weeks

Anti-COX1 Rabbit Polyclonal Antibody 

 

General information 

Cat. No. :SB-GB112401
Size :100 uL
Protein full name :Prostaglandin G/H synthase 1
Synonym :Cyclooxygenase-1, COX-1, PGH synthase 1, PGHS-1, PHS 1, Ptgs1, Cox1,
    Prostaglandin H2 synthase 1, Prostaglandin-endoperoxide synthase 1
Immunogen :Recombinant protein corresponding to Mouse COX1 / Cyclooxygenase 1
Isotype :IgG
Purity :Affinity purification
Subcellular location :Endoplasmic reticulum
Uniprot ID :P22437, Q63921
Storage :Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles.
Shipping Condition  :Dry Ice 
Storage Buffer :PBS with 0.02% sodium azide,100 μg/ml BSA and 50% glycerol.


Application
 
Applications Species Dilution Positive Tissue
IHC Human, Rat 1: 400-1: 800 liver, duodenum, skin, spleen, intestine
IF Human, Rat 1: 400-1: 800 duodenum, lung


Description


PTGS1(Prostaglandin G/H synthase 1) belongs to the prostaglandin G/H synthase family and catalyzes the conversion of arachidonic acid to prostaglandin H2, which is subsequently metabolized to various biologically active prostaglandins. It is also named as COX1(Cyclooxygenase-1). There is no PTGS1 expression in fetal samples (prostate, seminal vesicles, or ejaculatory ducts), and only minimal expression in adult tissues .

 
GB112399-1.png

Immunohistochemistry analysis of paraffin-embedded mouse liver using COX1 (GB112399) at dilution of 1: 800

GB112399-2.png

Immunohistochemistry analysis of paraffin-embedded rat liver using COX1 (GB112399) at dilution of 1: 800

 
GB112399-3.png

Immunohistochemistry analysis of paraffin-embedded mouse duodenum using COX1 (GB112399) at dilution of 1: 800

 
GB112399-4.png

Immunohistochemistry analysis of paraffin-embedded rat duodenum using COX1 (GB112399) at dilution of 1: 800

 
GB112399-5.png

Immunohistochemistry analysis of paraffin-embedded mouse skin using COX1 (GB112399) at dilution of 1: 800

 
GB112399-6.png

Immunohistochemistry analysis of paraffin-embedded rat spleen using COX1 (GB112399) at dilution of 1: 800

 
GB112399-8.png

Immunohistochemistry analysis of paraffin-embedded rat intestine using COX1 (GB112399) at dilution of 1: 800

GB112399-9.png
Immunofluorescent analysis of paraformaldehyde-fixed mouse duodenum using COX1 (GB112399) at dilution of 1: 650
GB112399-10.png

Immunofluorescent analysis of paraformaldehyde-fixed rat lung using COX1 (GB112399) at dilution of 1: 650

 

Human Diseases
  • Cardiovascular Diseases: Inhibition of COX-1 can reduce thromboxane A2, impacting platelet aggregation and cardiovascular events.
  • Gastrointestinal Disorders: COX-1 is involved in maintaining gastric mucosal integrity; its inhibition can lead to ulcers and gastrointestinal bleeding.
  • Inflammatory Conditions: Elevated COX-1 activity has been linked to chronic inflammatory diseases, including rheumatoid arthritis and osteoarthritis.

Cellular Signaling Pathways
  • Arachidonic Acid Pathway: COX-1 catalyzes the conversion of arachidonic acid to prostaglandins, which are critical mediators in inflammation and pain.
  • Platelet Activation Pathway: COX-1-derived thromboxane A2 promotes platelet aggregation, influencing hemostasis.
  • Gastric Protection Pathway: Prostaglandins produced by COX-1 play a protective role in the gastric mucosa by stimulating mucus and bicarbonate secretion.

Aliases for COX-1 Gene
  • GeneCards Symbol: PTGS1 2 
  • Prostaglandin-Endoperoxide Synthase 1 2 3 4 5
  • PGHS-1 2 3 4 5
  • COX1 2 3 4 5
  • Cyclooxygenase-1 2 3 4
  • PTGHS 2 3 5
  • Prostaglandin-Endoperoxide Synthase 1 (Prostaglandin G/H Synthase And Cyclooxygenase) 2 3
  • Prostaglandin G/H Synthase 1 3 4
  • Prostaglandin H2 Synthase 1 3 4
  • PGH Synthase 1 3 4
  • EC 1.14.99.1 4 49
  • EC 1.14.99 49
  • PGG/HS 3
  • PCOX1 3
  • PES-1 3
  • PGHS1 3
  • COX-1 4
  • PHS 1 4
  • COX3 3
  • PHS1 3

References 
  • Rouzer, Carol A, and Lawrence J Marnett. “Cyclooxygenases: Structural and Functional Insights.” Journal of Lipid Research, U.S. National Library of Medicine, Apr. 2009, www.ncbi.nlm.nih.gov/pmc/articles/PMC2674713/. 
  • Pannunzio, Alessandra, and Mauro Coluccia. “Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature.” MDPI, Multidisciplinary Digital Publishing Institute, 11 Oct. 2018, www.mdpi.com/1424-8247/11/4/101. 
  • Smith, C J, et al. “Pharmacological Analysis of Cyclooxygenase-1 in Inflammation.” Proceedings of the National Academy of Sciences of the United States of America, U.S. National Library of Medicine, 27 Oct. 1998, www.ncbi.nlm.nih.gov/pmc/articles/PMC23795/. 
  • Chandrasekharan, NV, and Daniel L Simmons. “The Cyclooxygenases - Genome Biology.” BioMed Central, BioMed Central, 27 Aug. 2004, genomebiology.biomedcentral.com/articles/10.1186/gb-2004-5-9-241. 
 

Satisfaction
Quality Rating
Value Rating
Style Rating
X